The Market Reports

Synopsis
The global market for POC HbA1C Testing was estimated to be worth US$ 550 million in 2024 and is forecast to a readjusted size of US$ 984 million by 2031 with a CAGR of 8.8% during the forecast period 2025-2031.
HbA1c levels, which reflect the average plasma glucose concentration over the preceding three months, play a pivotal role in the diagnosis, assessment, and monitoring of diabetes. HbA1c is your average blood glucose (sugar) levels for the last two to three months. The immediate feedback of HbA1c levels is highly effective for controlling plasma glucose levels and point-of-care (POC) instruments, characterized as fast, portable, and easy-to-use, have been shown to be suitable for providing rapid feedback of HbA1c levels. In this report, we mainly study the devices for POC HbA1C Testing without services.
Market Drivers:
The growing prevalence of diabetes worldwide is a key driver for the POC HbA1c testing market. As the number of diabetic and prediabetic patients continues to rise, there is an increasing need for quick and efficient monitoring solutions to manage blood sugar levels effectively. POC HbA1c testing provides immediate results, allowing for real-time clinical decision-making and reducing patient dependence on centralized laboratories. Additionally, advancements in technology have led to the development of highly accurate, portable, and user-friendly devices, expanding their adoption in hospitals, clinics, and even home settings. Government initiatives promoting early diabetes detection and personalized treatment plans further boost market growth.
Market Challenges:
Despite its advantages, POC HbA1c testing faces several challenges, including high costs and reimbursement limitations in some healthcare systems, which may hinder widespread adoption. Additionally, variations in accuracy and standardization among different POC devices pose concerns regarding result reliability, especially when compared to laboratory-based testing. Regulatory approvals and compliance with stringent quality standards also create barriers for manufacturers entering new markets. Furthermore, lack of awareness and limited access to POC testing in certain developing regions restricts its potential reach, requiring further investments in education and healthcare infrastructure.
This report aims to provide a comprehensive presentation of the global market for POC HbA1C Testing, focusing on the total sales revenue, key companies market share and ranking, together with an analysis of POC HbA1C Testing by region & country, by Type, and by Application.
The POC HbA1C Testing market size, estimations, and forecasts are provided in terms of sales revenue ($ millions), considering 2024 as the base year, with history and forecast data for the period from 2020 to 2031. With both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding POC HbA1C Testing.
Market Segmentation
By Company
Abbott
Siemens Healthineers
Roche
Bio-Rad
GREEN CROSS MEDIS
Trinity Biotech
HUMAN Diagnostics
Sinocare (PTS Diagnostics)
Erba Diagnostics
EKF Diagnostics
OSANG Healthcare
SD Biosensor
Aidian
Boditech Med
i-SENS
Segment by Type
Immunoassay
Boronate Affinity
Others
Segment by Application
Hospital and Clinics
Diagnostic Laboratories
Others
By Region
North America
United States
Canada
Asia-Pacific
China
Japan
South Korea
Southeast Asia
India
Australia
Rest of Asia-Pacific
Europe
Germany
France
U.K.
Italy
Netherlands
Nordic Countries
Rest of Europe
Latin America
Mexico
Brazil
Rest of Latin America
Middle East & Africa
Turkey
Saudi Arabia
UAE
Rest of MEA
Chapter Outline
Chapter 1: Introduces the report scope of the report, global total market size. This chapter also provides the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 2: Detailed analysis of POC HbA1C Testing company competitive landscape, revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 3: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 4: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 5: Revenue of POC HbA1C Testing in regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the market development, future development prospects, market space, and market size of each country in the world.
Chapter 6: Revenue of POC HbA1C Testing in country level. It provides sigmate data by Type, and by Application for each country/region.
Chapter 7: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product revenue, gross margin, product introduction, recent development, etc.
Chapter 8: Analysis of industrial chain, including the upstream and downstream of the industry.
Chapter 9: Conclusion.

Index